| Literature DB >> 21635940 |
M A Mvondo1, D Njamen, S Tanee Fomum, J Wandji, Günter Vollmer.
Abstract
To determine whether the two major compounds of Erythrina lysistemon are active principles accounting for Erythrina estrogenic effects, we used a postmenopause-like model of ovariectomized Wistar rats to evaluate their effects on some menopausal problems. Ovariectomized rats were orally treated either with compound 1 or compound 2 at 1 and 10 mg/kg BW for 28 days. Estradiol valerate served as the reference substance. As results, compounds 1 and 2 displayed estrogen-like effects on the uterus and the vagina, and reduced atherogenic risks by decreasing the two assessed atherogenic parameters, the total cholesterol/HDL-cholesterol ratio and the atherogenic index of plasma.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21635940 DOI: 10.1016/j.fitote.2011.05.009
Source DB: PubMed Journal: Fitoterapia ISSN: 0367-326X Impact factor: 2.882